Loading...
HomeMy WebLinkAboutMINUTES - 05122015 - C.52RECOMMENDATION(S): Approve and authorize the Purchasing Agent, on behalf of the Health Services Department to execute an amendment to Purchase Order #53110 with Bio-Rad Laboratories, Inc., to add $85,000 for a new total of $285,000 for reagents and supplies to perform chemistry and microbiology testing for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC), with no change in the original term of July 1, 2014 through June 30, 2015. FISCAL IMPACT: 100% funding is included in the Hospital Enterprise Fund I Budget. BACKGROUND: CCRMC’s Clinical Laboratory uses Bio-Rad Laboratories, Inc. reagents, various controls, methicillin resistant staphylococcus aureus (MRSA) media, and supplies for chemistry, urinalysis and microbiology departments. These are used to perform tests on patients for various conditions and to check for infections. CONSEQUENCE OF NEGATIVE ACTION: If this Purchase Order is not approved, the CCRMC Clinical Laboratory will not be able to perform patient testing, thus impacting patient safety and health. APPROVE OTHER RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE Action of Board On: 05/12/2015 APPROVED AS RECOMMENDED OTHER Clerks Notes: VOTE OF SUPERVISORS AYE:John Gioia, District I Supervisor Candace Andersen, District II Supervisor Mary N. Piepho, District III Supervisor Karen Mitchoff, District IV Supervisor ABSENT:Federal D. Glover, District V Supervisor Contact: Anna Roth, 370-5101 I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown. ATTESTED: May 12, 2015 David Twa, County Administrator and Clerk of the Board of Supervisors By: Chris Heck, Deputy cc: T Scott, C Rucker, Crystal Grayson C. 52 To:Board of Supervisors From:William Walker, M.D., Health Services Director Date:May 12, 2015 Contra Costa County Subject:Bio-Rad Laboratories, Inc. Purchase Order Amendment CHILDREN'S IMPACT STATEMENT: Not applicable.